Graves disease (GD) affects 0.2% to 1.3% of the global population and is the most common cause of hyperthyroidism and the result of autoantibodies (TRAbs) to the thyrotropin receptor (TSHR). This evidence concerns the gene TSHR and hyperthyroidism.